# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from...
Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive (NYSE:CL) with a Outperform and raises the price ta...
Deutsche Bank analyst Steve Powers maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $98 to ...
Cannabis ancillary company EnWave Corporation (TSX-V: ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as...
Illinois' retail cannabis sales reached the $1 billion mark year-to-date, Gov. JB Pritzker's office announced Wednesday...
Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $103 to ...
B of A Securities analyst Bryan Spillane maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $...
Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $...